Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Correction: CDK1 Is a Syntheti...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.

Show other versions (1)
Bibliographic Details
Main Authors: Sara Costa-Cabral, Rachel Brough, Asha Konde, Marieke Aarts, James Campbell, Eliana Marinari, Jenna Riffell, Alberto Bardelli, Christopher Torrance, Christopher J Lord, Alan Ashworth
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4835098?pdf=render
  • Holdings
  • Description
  • Other Versions (1)
  • Similar Items
  • Staff View

Internet

http://europepmc.org/articles/PMC4835098?pdf=render

Similar Items

  • CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    by: Sara Costa-Cabral, et al.
    Published: (2016-01-01)
  • Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    by: Sara Costa-Cabral, et al.
    Published: (2017-01-01)
  • Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours.
    by: Sara Costa-Cabral, et al.
    Published: (2018-01-01)
  • A combination therapy for KRAS-mutant lung cancer by targeting synthetic lethal partners of mutant KRAS
    by: Xiufeng Pang, et al.
    Published: (2016-10-01)
  • ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A
    by: Chris T. Williamson, et al.
    Published: (2016-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs